Learn More
Medchemexpress LLC Ebaresdax | 1334471-39-4 | 99.9% | C12H14N2O3S | 10MG

Supplier: Medchemexpress LLC HY13956910MG
Ebaresdax (ACP-044) is an investigational analgesic research compound reported to inhibit SIN-1-derived peroxynitrite oxidation and peroxynitrite-mediated cytotoxicity. It is provided for research use only and is intended for in vitro studies of peroxynitrite-related signaling and cytotoxic mechanisms.
- Displays potent inhibition of peroxynitrite oxidation (IC50 = 3.7 ± 0.80 μM).
- Reduces peroxynitrite-mediated cytotoxicity (IC50 = 0.13 ± 0.02 μM).
- High purity and well characterized for research applications.
- Available in solid and solution formats for flexible assay setup.
- Supplied with supporting analytical documents (datasheet, COA, SDS).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.